4 unknown, 1 active not recruiting, 1 suspended. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 3 | Active not recruiting 1, Suspended 1, Unknown 1 |
Follow Platinum-Based Drug: new trials by email Literature Review of Platinum-Based Drug trials Research Report on Platinum-Based Drug
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy radiotherapy, Platinum-Based Drug, Immunotherapy - Non-small Cell Lung Cancer Stage III | Phase 3 | Unknown | Zhejiang Cancer Hospital | 105 | 2023-09-15 | 2023-09-13 |
| A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Toripalimab injection (JS001), Paclitaxel, Albumin-Bound, Radiotherapy - Esophageal Squamous Cell Carcinoma | Phase 2 | Suspended | Zhejiang Cancer Hospital | 100 | 2019-09-07 | 2021-02-23 |
| Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC) Platinum-Based Drug, Conventional chemotherapy - Ovarian Cancer, Ovarian Neoplasms | Phase 2 / Phase 3 | Unknown | Blokhin's Russian Cancer Research Center | 164 | 2019-09-01 | 2019-08-13 |
| Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02 SIB-IMRT, Paclitaxel, Platinum-Based Drug - Esophageal Neoplasms | Phase 3 | Unknown | Chinese Academy of Medical Sciences | 164 | 2017-12-01 | 2019-01-02 |
| Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03 SIB-IMRT, Paclitaxel, Platinum-Based Drug - IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer | Phase 3 | Unknown | Chinese Academy of Medical Sciences | 2 | 2017-09-01 | 2019-01-02 |
| Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC Durvalumab, Tremelimumab, Platinum-Based Drug - Lung Cancer Metastatic | Phase 2 | Active not recruiting | Canadian Cancer Trials Group | 301 | 2017-03-28 | 2026-09-01 |
Carcinoma, Non-Small-Cell Lung (1) · Cystadenocarcinoma, Serous (1) · Esophageal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Ovarian Neoplasms (1) · Radiation Pneumonitis (1)
Chinese Academy of Medical Sciences (2) · Zhejiang Cancer Hospital (2) · Blokhin's Russian Cancer Research Center (1) · Canadian Cancer Trials Group (1)
China (3) · Australia (1) · Canada (1) · Russia (1)
Chen Ming, MD (1) · Natasha Leighl (1) · Xu Yujin, PhD (1) · Yujin Xu, MD (1) · Zefen Xiao, MD (1)